{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:13:00Z","timestamp":1775776380385,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.yebeh.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T11:23:46Z","timestamp":1446809026000},"page":"212-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"PA","title":["Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy"],"prefix":"10.1016","volume":"52","author":[{"given":"Janki","family":"Bhakta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelyn","family":"Bainbridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3005-1533","authenticated-orcid":false,"given":"Laura","family":"Borgelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2015.08.004_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0010","unstructured":"Carbamazepine. In: DRUGDEX\u00ae System [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. [Updated periodically, accessed September 18, 2014]."},{"key":"10.1016\/j.yebeh.2015.08.004_bb0015","unstructured":"Ethosuximide. In: DRUGDEX\u00ae System [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. [Updated periodically, accessed September 18, 2014]."},{"key":"10.1016\/j.yebeh.2015.08.004_bb0020","unstructured":"Fosphenytoin. In: DRUGDEX\u00ae System [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. [Updated periodically, accessed September 18, 2014]."},{"key":"10.1016\/j.yebeh.2015.08.004_bb0025","unstructured":"Phenobarbital. In: DRUGDEX\u00ae System [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. [Updated periodically, accessed September 18, 2014]."},{"key":"10.1016\/j.yebeh.2015.08.004_bb0030","unstructured":"Phenytoin. In: DRUGDEX\u00ae System [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. [Updated periodically, accessed September 18, 2014]."},{"key":"10.1016\/j.yebeh.2015.08.004_bb0035","unstructured":"Primidone. In: DRUGDEX\u00ae System [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. [Updated periodically, accessed September 18, 2014]."},{"key":"10.1016\/j.yebeh.2015.08.004_bb0040","unstructured":"Topiramate. In: DRUGDEX\u00ae System [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. [Updated periodically, accessed September 18, 2014]."},{"key":"10.1016\/j.yebeh.2015.08.004_bb0045","unstructured":"Valproic acid. In: DRUGDEX\u00ae System [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. Updated periodically. Accessed September 18, 2014."},{"key":"10.1016\/j.yebeh.2015.08.004_bb0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0890-6238(01)00199-X","article-title":"The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures","volume":"16","author":"Matalon","year":"2002","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2125.1984.tb02528.x","article-title":"Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status","volume":"18","author":"Kuhnz","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0065","series-title":"Product Information","year":"2003"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0022-3565(25)21993-0","article-title":"Fetal anticonvulsant syndrome in rats: dose- and period-response relationships of prenatal diphenylhydantoin, trimethadione and phenobarbital exposure on the structural and functional development of the offspring","volume":"227","author":"Vorhees","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0890-6238(91)90090-3","article-title":"Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: animal studies","volume":"5","author":"Finnell","year":"1991","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yebeh.2007.08.009","article-title":"Cognitive\/behavioral teratogenetic effects of antiepileptic drugs","volume":"11","author":"Meador","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1586\/ern.10.57","article-title":"Teratogenic effects of antiepileptic drugs","volume":"10","author":"Hill","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0090","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/ajmg.a.35438","article-title":"Antiepileptic drugs and pregnancy outcomes","volume":"158A","author":"Wlodarczyk","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0095","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0022-3476(84)80295-4","article-title":"Four siblings with similar malformations after exposure to phenytoin and primidone","volume":"105","author":"Krauss","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0022-3476(81)80986-9","article-title":"Teratogenic effects associated with maternal primidone therapy","volume":"99","author":"Myhre","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-3476(79)80173-0","article-title":"A possible primidone embryopathy","volume":"94","author":"Rudd","year":"1979","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0110","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0022-3476(82)80609-4","article-title":"Primidone teratogenicity or Noonan syndrome?","volume":"100","author":"Burn","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.reprotox.2015.03.003","article-title":"First trimester exposure to topiramate and the risk of oral clefts in the offspring: a systematic review and meta-analysis","volume":"53","author":"Alsaad","year":"2015","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0120","first-page":"321","article-title":"Effect of prenatal administration of therapeutic doses of topiramate on ossification of ribs and vertebrae in rat fetuses","volume":"53","author":"Fadel","year":"2012","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0125","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.0013-9580.2004.451102.x","article-title":"North American antiepileptic drug pregnancy registry","volume":"45","author":"Holmes","year":"2004","journal-title":"Epilepsia"},{"issue":"405","key":"10.1016\/j.yebeh.2015.08.004_bb0130","first-page":"e1","article-title":"Use of topiramate in pregnancy and risk of oral clefts","volume":"207","author":"Margulis","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0135","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000318293.28278.33","article-title":"Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register","volume":"71","author":"Hunt","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0140","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0140-6736(84)92079-8","article-title":"Valproate and spina bifida","volume":"2","author":"Robert","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(84)90557-9","article-title":"Spina bifida and in-utero exposure to valproate","volume":"2","author":"Lindhout","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0150","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3476(86)80949-0","article-title":"Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid","volume":"108","author":"Jager-Roman","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0155","first-page":"441","article-title":"Major malformations with valproic acid","volume":"52","author":"Koren","year":"2006","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0160","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","article-title":"Increased rate of major malformations in offspring exposed to valproate during pregnancy","volume":"64","author":"Wyszynski","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0165","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ncl.2009.06.006","article-title":"Teratogenic effects of antiepileptic medications","volume":"27","author":"Tomson","year":"2009","journal-title":"Neurol Clin"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0170","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/bmj.39266.473113.BE","article-title":"Epilepsy in pregnancy","volume":"335","author":"Tomson","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.yebeh.2007.08.015","article-title":"Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries","volume":"11","author":"Tomson","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002018-200427030-00004","article-title":"Malformation rates in children of women with untreated epilepsy: a meta-analysis","volume":"27","author":"Fried","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.70.1.15","article-title":"Additional educational needs in children born to mothers with epilepsy","volume":"70","author":"Adab","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0190","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/01.WNL.0000154514.82948.69","article-title":"Neuropsychological effects of exposure to anticonvulsant medication in utero","volume":"64","author":"Vinten","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/WNL.62.1.28","article-title":"Normal intelligence in children with prenatal exposure to carbamazepine","volume":"62","author":"Gaily","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0200","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2005.06.001","article-title":"Children exposed to valproate in utero\u2014population based evaluation of risks and confounding factors for long-term neurocognitive development","volume":"65","author":"Eriksson","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0210","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0215","first-page":"1","article-title":"Intended and unintended births in the United States: 1982\u20132010","author":"Mosher","year":"2012","journal-title":"Natl Health Stat Rep"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jnnp.72.1.114","article-title":"Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice","volume":"72","author":"Shorvon","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0225","unstructured":"Alan Guttmacher Institute. Fact sheet: contraceptive use in the United States. July 2015. Available at: http:\/\/www.guttmacher.org\/pubs\/fb_contr_use.html [Accessed September 10, 2015]."},{"key":"10.1016\/j.yebeh.2015.08.004_bb0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/ecp.10.3","article-title":"Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives","volume":"3","author":"Reddy","year":"2010","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0235","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0240","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.yebeh.2009.01.024","article-title":"Antiepileptic drugs: are women aware of interactions with oral contraceptives and potential teratogenicity?","volume":"14","author":"Pack","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yebeh.2004.11.006","article-title":"Knowledge of women's issues and epilepsy (KOWIE-II): a survey of health care professionals","volume":"6","author":"Long","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0250","author":"American Academy of Neurology"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0255","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1783\/147118909788708002","article-title":"The safety of anti-epileptic drug regimens: a qualitative study of factors determining the success of counselling women before conception","volume":"35","author":"Pashley","year":"2009","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0260","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/seiz.1999.0325","article-title":"Proactive pre-conception counselling for women with epilepsy\u2014is it effective?","volume":"8","author":"Betts","year":"1999","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0265","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.seizure.2013.10.003","article-title":"Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes","volume":"23","author":"Abe","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yebeh.2012.03.001","article-title":"Patient knowledge about issues related to pregnancy in epilepsy: a cross-sectional study","volume":"24","author":"Metcalfe","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0275","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1059-1311(03)00085-2","article-title":"Understanding the information needs of women with epilepsy at different lifestages: results of the \u2018Ideal World\u2019 survey","volume":"12","author":"Crawford","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yebeh.2006.09.013","article-title":"Epilepsy and women's health issues: unmet needs\u2014survey results from women with epilepsy","volume":"10","author":"Vazquez","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.contraception.2011.04.017","article-title":"Co-prescription of antiepileptic drugs and contraceptives","volume":"85","author":"Wang","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0290","author":"HRA Pharma UK"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0295","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1210\/jcem-48-5-816","article-title":"In vivo metabolism of progestins. V. The effect of protocol design on the estimated metabolic clearance rate and volume of distribution of medroxyprogesterone acetate in women","volume":"48","author":"Gupta","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0300","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1783\/147118910793048764","article-title":"Contraception for women taking antiepileptic drugs","volume":"36","author":"O'Brien","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0305","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1783\/147118902101195992","article-title":"Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs","volume":"28","author":"Bounds","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.yebeh.2015.08.004_bb0310","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00023210-200216040-00005","article-title":"Interactions between antiepileptic drugs and hormonal contraception","volume":"16","author":"Crawford","year":"2002","journal-title":"CNS Drugs"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501500462X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501500462X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T10:11:52Z","timestamp":1748686312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501500462X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":62,"alternative-id":["S152550501500462X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.08.004","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}